Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation

NCT02431988 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

PROCEDURE: Leukapheresis
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: CAR19 T-Cells

Sponsor

University College, London